Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance

Oncology Reports

Volumn 24, Issue 2, 2010, Pages 501-505

  Honoki, Kanya ^a   Fujii, Hiromasa ^a   Kubo, Atsushi ^a   Kido, Akira ^a   Mori, Toshio ^a   Tanaka, Yasuhito ^a   Tsujiuchi, Toshifumi ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Aldehyde dehydrogenase 1; Cancer stem cell; Drug resistance; Sarcoma

Indexed keywords

ALDEHYDE DEHYDROGENASE; CISPLATIN; DOXORUBICIN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ANTINEOPLASTIC AGENT; ISOENZYME; RETINAL DEHYDROGENASE;

ARTICLE; CANCER STEM CELL; CELL SELECTION; CELL SUBPOPULATION; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; FIBROSARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; BIOLOGICAL MODEL; BONE NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; PHYSIOLOGY; SARCOMA; TUMOR CELL CULTURE; UPREGULATION;

ALDEHYDE DEHYDROGENASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; RETINAL DEHYDROGENASE; SARCOMA; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 77954351665     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000885     Document Type: Article

References (32)

1. Sell S: Stem cell origin cancer and differentiation therapy. Crit Rev Oncol Hematol 51: 1-28, 2004.
2. Reya T, Morison SJ, Clarke MF and Weissman IL: Stem cells, cancer and cancer stem cells. Nature 414: 105-111, 2001.
3. Molofsky AV, Pardel R and Morrison SJ: Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 16: 700-707, 2004.
4. Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737, 1997.
5. Al-Haji M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
6. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumor initiating cells. Nature 43: 396-401, 2004.
7. Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951, 2005.
8. Fang D, Nguyen TK, Leishear K, et al: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9337, 2005.
9. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 445: 106-110, 2006.
10. Li C, Heidt DG, Dalerba P, et al: Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037, 2007.
11. Prince ME, Sivanandan R, Kaczorowski A, et al: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973-978, 2007.
12. Taussig DC, Pearce DJ, Simpson C, et al: Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood 106: 4086-4092, 2005.
13. Russo JE and Hilton J: Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res 48: 2963-2968, 1988.
14. Magni M, Shammah S, Schiro R, Mellado W, Dalla-Favera R and Gianni AM: Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 87: 1097-1103, 1996. (Pubitemid 26043537)
15. Chute JP, Muramoto GG, Whitesides J, et al: Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 103: 11707-11712, 2006.
16. Sahovic EA, Colvin M, Hilton J and Ogawa M: Role for aldehyde dehydrogenase in survival of progenitors for murine blast cell colonies after treatment with 4-hydroperoxycyclophosphamide in vitro. Cancer Res 48: 1223-1226, 1988. (Pubitemid 18075537)
17. Storms RW, Trujillo AP, Springer JB, et al: Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA 96: 9118-9123, 1996.
18. Sladek NE, Kollander R, Sreerama L and Kiang DT: Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic response to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemother Pharmacol 49: 309-321, 2002.
19. Pearce DJ, Taussig D, Simpson C, et al: Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 23: 752-760, 2005.
20. Ginestier C, Hur MH, Charafe-Jauffret E, et al: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567, 2007.
21. Jones RJ, Barber JP, Vala MS, et al: Assessment of aldehyde dehydrogenase in viable cells. Blood 85: 2742-2746, 1995.
22. Gibbs CP, Kukekov VG, Reith JD, et al: Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 7: 967-976, 2005.
23. Fujii H, Honoki K, Tsujiuchi T, et al: Reduced expression of INK4a/ARF genes in stem-like sphere cells from rat sarcomas. Biochem Biophys Res Commun 362: 773-778, 2007.
24. Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K and Takakura Y: Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol 34: 1381-1386, 2009.
25. Hadnagy A, Gaboury L, Beauliue R and Balicki D: SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 312: 3701-3710, 2006.
26. Smalley MJ and Clarke RB: The mammary gland 'side population': a putative stem/progenitor cell marker? J Mammary Gland Biol Neoplasia 10: 37-47, 2005.
27. Hess DA, Meyerrose TE, Wirthlin L, et al: Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104: 1648-1655, 2004.
28. Armstrong L, Stojkovic M, Dimmick I, et al: Phenotypic characterization of murine primitive hematopoietic progeniotor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 22: 1142-1151, 2004.
29. Siegel GM, Campbell LM, Narayan M and Gonzalez-Fernandez F: Cancer stem cell characteristics in retinoblastoma. Mol Vis 12: 729-737, 2005.
30. Kim H, Lapointe J, Kaygusuz G, et al: The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res 65: 8118-8124, 2005.
31. Takahashi K and Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006.
32. Takahashi K, Tanabe K, Ohnuki M, et al: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872, 2007.